136 related articles for article (PubMed ID: 7472745)
1. Osteosarcoma oncogene expression detected by in situ hybridization.
Wang H; Rodgers WH; Chmell MJ; Svitek C; Schwartz HS
J Orthop Res; 1995 Sep; 13(5):671-8. PubMed ID: 7472745
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas.
Franchi A; Arganini L; Baroni G; Calzolari A; Capanna R; Campanacci D; Caldora P; Masi L; Brandi ML; Zampi G
J Pathol; 1998 Jul; 185(3):284-9. PubMed ID: 9771482
[TBL] [Abstract][Full Text] [Related]
4. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
5. Detection of c-fos expression in benign and malignant musculoskeletal lesions.
Weisstein JS; Majeska RJ; Klein MJ; Einhorn TA
J Orthop Res; 2001 May; 19(3):339-45. PubMed ID: 11398843
[TBL] [Abstract][Full Text] [Related]
6. Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression.
Kloen P; Gebhardt MC; Perez-Atayde A; Rosenberg AE; Springfield DS; Gold LI; Mankin HJ
Cancer; 1997 Dec; 80(12):2230-9. PubMed ID: 9404699
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Shattuck-Brandt RL; Lamps LW; Heppner Goss KJ; DuBois RN; Matrisian LM
Mol Carcinog; 1999 Mar; 24(3):177-87. PubMed ID: 10204802
[TBL] [Abstract][Full Text] [Related]
8. c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos.
Wang ZQ; Liang J; Schellander K; Wagner EF; Grigoriadis AE
Cancer Res; 1995 Dec; 55(24):6244-51. PubMed ID: 8521421
[TBL] [Abstract][Full Text] [Related]
9. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
Ferracini R; Di Renzo MF; Scotlandi K; Baldini N; Olivero M; Lollini P; Cremona O; Campanacci M; Comoglio PM
Oncogene; 1995 Feb; 10(4):739-49. PubMed ID: 7862451
[TBL] [Abstract][Full Text] [Related]
10. Discordant effects of activator protein-1 transcription factor on gene regulation, invasion, and metastasis in spontaneous, radiation-induced, and fos-induced osteosarcomas.
Rupp B; Lorenz U; Schmidt J; Werenskiold AK
Mol Carcinog; 1998 Oct; 23(2):69-75. PubMed ID: 9808160
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
[TBL] [Abstract][Full Text] [Related]
12. HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study.
Somers GR; Ho M; Zielenska M; Squire JA; Thorner PS
Pediatr Dev Pathol; 2005; 8(5):525-32. PubMed ID: 16211448
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression.
Bodey B; Taylor CR; Siegel SE; Kaiser HE
Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
15. [Detection of c-sis transcripts and PDGF-like products by in situ hybridization and immunohistochemical study].
Nakajima H
Nihon Seikeigeka Gakkai Zasshi; 1989 Oct; 63(10):1221-7. PubMed ID: 2584831
[TBL] [Abstract][Full Text] [Related]
16. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Bolon I; Brambilla E; Vandenbunder B; Robert C; Lantuejoul S; Brambilla C
Lab Invest; 1996 Jul; 75(1):1-13. PubMed ID: 8683934
[TBL] [Abstract][Full Text] [Related]
17. Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation.
Sunters A; McCluskey J; Grigoriadis AE
Dev Genet; 1998; 22(4):386-97. PubMed ID: 9664690
[TBL] [Abstract][Full Text] [Related]
18. Expression of collagenase-3 (MMP-13) in c-fos-induced osteosarcomas and chondrosarcomas is restricted to a subset of cells of the osteo-/chondrogenic lineage.
Tuckermann JP; Vallon R; Gack S; Grigoriadis AE; Porte D; Lutz A; Wagner EF; Schmidt J; Angel P
Differentiation; 2001 Dec; 69(1):49-57. PubMed ID: 11776394
[TBL] [Abstract][Full Text] [Related]
19. Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning.
Olstad OK; Gautvik VT; Reppe S; Rian E; Jemtland R; Ohlsson C; Bruland OS; Gautvik KM
Anticancer Res; 2003; 23(3B):2201-16. PubMed ID: 12894494
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells.
Subramaniam M; Oursler MJ; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1995 Jan; 57(1):52-61. PubMed ID: 7721958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
